Article Details
Retrieved on: 2022-11-14 09:19:20
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
OSLO, Norway, Nov. 14, 2022 /PRNewswire/ -- Lytix Biopharma ("Lytix") (Euronext Growth Oslo: LYTIX), a Norwegian immuno-oncology company, today ...
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here